These results suggest combined infection plus treatment with anti-resorptive agents promotes TNFα expression in osteoclast progenitors, and anti-resorptive agents convert the osteoclast progenitor cells into TNFα-expressing macrophages even in the presence of RANKL. The gene discussed is TNF; the disease is infection.